Detailed Narrative
Q3 & 9M FY25 Financial Performance Overview
Bodal Chemicals reported a robust Q3 FY25 with consolidated revenue of Rs. 446 crores, marking a 30% year-on-year growth. Consolidated EBITDA stood at Rs. 46 crores, a 63% increase YoY, with an EBITDA margin of 10.4%. For the nine-month period (9M FY25), consolidated revenue reached Rs. 1,304 crores, up 28% YoY, and EBITDA grew 36% YoY to Rs. 121 crores. However, consolidated PAT for Q3 FY25 was Rs. 5.4 crores, and for 9M FY25, it was Rs. 4 crores, indicating some pressure on net profitability.
Dye Intermediates and Dyestuffs Segment Performance
The dye intermediates division showed strong performance, with 9M FY25 revenue of Rs. 507 crores, a 53% YoY growth. Q3 FY25 revenue for this segment was Rs. 179 crores, growing 4% QoQ, driven by improved volumes and realizations (H-Acid at ~Rs. 490/kg, Vinyl Sulphone at ~Rs. 242/kg). In contrast, the dyestuffs segment experienced an 8% QoQ degrowth in Q3 FY25, with revenue of Rs. 114 crores, though 9M FY25 revenue was Rs. 373 crores (up 6% YoY). The company plans to restart salt-free dye production at its Unit 4 in Ahmedabad to capitalize on new opportunities.
Benzene Downstream Project Update and Outlook
The Saykha Greenfield benzene downstream project has achieved quality norms but contributed nominally to Q3 revenue due to low utilization (13-14%). Its capitalization, however, led to increased overheads, partially offsetting profitability. Management expects significant ramp-up, targeting 60-70% plus utilization in the next 1-2 months and 80% plus utilization in FY26, which is projected to add Rs. 250-300 crores to the topline and contribute 12-14% to EBITDA annually. The project requires specific certifications to cater to the pharma industry, a major target market.
Debt Management and Capital Allocation Strategy
The company's long-term debt stands at Rs. 540 crores, with working capital debt at Rs. 300 crores. Management aims to reduce total debt by approximately Rs. 200 crores by March 2026, partly through the liquidation of non-core assets, expecting Rs. 60-70 crores from this. The benzene project was funded with 70% debt and 30% internal accruals. The cost of debt is around 9%. The company is not considering any equity raising and plans no major CAPEX in the next 4-6 quarters, focusing on consolidating existing investments.
Punjab Caustic Soda Plant Subsidy and Other Business Segments
The Rs. 45 crore subsidy from the Punjab Caustic Soda Plant is in its final approval stage at the state level, with cash flow expected from the next quarter, followed by Rs. 20 crores annually for seven years. The basic chemicals segment reported 9M FY25 revenue of Rs. 73 crores (up 18%), and Chlor-Alkali achieved Rs. 243 crores (up 21% YoY) with 16% volume growth. The Turkish subsidiary, Sener Boya, recorded a Rs. 1.65 crore loss in Q3 FY25 due to hyperinflation.
Market Outlook and Margin Guidance
Management expressed confidence in the overall chemical industry recovery, noting improved volumes and demand. They project an annual turnover exceeding Rs. 2,000 crores and 12-15% EBITDA margins in the coming quarters, considering this a normalized and stable scenario. This guidance includes the anticipated Punjab subsidy and accounts for raw material price volatility. Current capacity utilization is high across most segments (90%+ for dye intermediates, basic chemicals, caustic), with dyestuffs at 56% and benzene derivatives ramping up from 13-14%.